Gene: COL3A1
Official Full Name: collagen type III alpha 1 chainprovided by HGNC
Gene Summary: This gene encodes the pro-alpha1 chains of type III collagen, a fibrillar collagen that is found in extensible connective tissues such as skin, lung, uterus, intestine and the vascular system, frequently in association with type I collagen. Mutations in this gene are associated with Ehlers-Danlos syndrome type IV, and with aortic and arterial aneurysms. [provided by R. Dalgleish, Feb 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03874 | COL3A1 Knockout cell line (HeLa) | Human | COL3A1 | 1:3~1:6 | Negative | Online Inquiry |
KO03875 | COL3A1 Knockout cell line (HEK293) | Human | COL3A1 | 1:3~1:6 | Negative | Online Inquiry |
KO03876 | COL3A1 Knockout cell line (A549) | Human | COL3A1 | 1:3~1:4 | Negative | Online Inquiry |
COL3A1 Gene Knockout Cell Lines are expertly engineered cellular models that are genetically modified to disrupt the expression of the COL3A1 gene, which encodes type III collagen—an important structural component of the extracellular matrix. These knockout cell lines provide invaluable tools for studying the biological functions of the COL3A1 gene, its role in connective tissue disorders, and its interactions in various cellular environments.
The primary mechanism of action in these cell lines involves the targeted disruption of COL3A1 using state-of-the-art genome editing technologies, such as CRISPR/Cas9 or RNA interference. By creating a loss-of-function model, researchers can observe the resulting phenotypic changes and investigate the implications on cellular behavior, signaling pathways, and tissue integrity. Understanding the role of COL3A1 is crucial for elucidating the pathogenesis of diseases such as Ehlers-Danlos syndrome and other disorders related to collagen deficiencies.
In both research and clinical settings, these cell lines are invaluable in drug discovery, disease modeling, and regenerative medicine. They can aid in screening therapies aimed at restoring normal collagen production or ameliorating the effects of collagen-related diseases. The capacity to perform high-throughput screening with COL3A1 knockout cell lines offers significant advantages in efficiency and specificity, providing insights that traditional models may not achieve.
What sets COL3A1 Gene Knockout Cell Lines apart from other genetic models is their precise gene editing, which acknowledges the complexity of the extracellular matrix while minimizing off-target effects. This specificity enhances the reliability of experimental results, making them more applicable to human health research compared to conventional knockout models.
Researchers and clinicians will find these cell lines invaluable for advancing understanding in collagen biology and developing targeted therapeutics. Leveraging our extensive expertise in genetic engineering and cellular biology, we are committed to providing high-quality products that drive innovation in the scientific community, empowering users to uncover novel solutions for complex biological challenges.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.